Navigation Links
Video: GEN Video Hits Home with Web Audience
Date:10/2/2007

NEW ROCHELLE, N.Y., Oct. 2 /PRNewswire/ -- Genetic Engineering and Biotechnology News' (GEN) first online video program has been viewed by over 850 visitors and picked up by more than 180 media outlets since its release earlier this month. The video, which is the first to run on GEN's Biotech Video Channel, is a corporate overview produced for GE Healthcare Life Sciences.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gen/29564/

"We are absolutely delighted with the response to our first online video project," said John Sterling, Editor-in-Chief, "The video has proven to be a perfect complement to the print and online editions of GEN."

GEN has expanded its GENcast network with the addition of a Biotech Video Channel. It is hosted on GEN's website, http://www.genengnews.com, which logs over 1,000,000 user sessions per month.

Sterling interviewed Ger Brophy, general manager of GE Healthcare's Advanced Systems, who discussed the company's strategy, technologies, and service capabilities. GEN selected GE Healthcare Life Sciences for its first corporate-profile video because the company's novel technologies and range of activities span life science R&D from drug discovery through bioprocess scale- up, which is similar to the breadth of GEN's coverage and extremely relevant to GEN's website audience.

"We are thrilled about the launch of GEN's Biotech Video Channel," stated Joan Boyce, GEN's Group Publisher. "This medium will provide our website visitors an exciting new way to stay abreast of technological advances fueling the biotech industry. It also offers solution providers a compelling context and distribution channel for their own videos."

Genetic Engineering & Biotechnology News is published 21 times a year in print, and its website, '/>"/>

SOURCE Genetic Engineering and Biotechnology News
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cut down TV and video games and you have less aggressive children.
2. Parents Should Beware of Violent Video Games
3. Children’s obesity linked to video game
4. Poland: Parental warning systems are likely to be adopted in video games.
5. Video Games, The Latest Craze Of American Adults
6. Interactive Video, Better Teaching Aid For Toddlers
7. Video Games Reduces Surgical Errors – A Stud
8. Fun And Cure With Video Games
9. Stroke Rehabilitation Through Modified Video Games
10. Videoconferencing, an impetus to Pediatric Oncology
11. Free Online Educational Videos for People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...But researchers remain cautious about future antib..., FRIDAY, Nov. 21 (HealthDay News) -- People with...disease (COPD) may be able to reduce the frequency... common antibiotic, a new report says. , The s... the American Journal of Respiratory and Critical...
(Date:11/21/2008)...MORGANTOWN, W.Va., Nov. 21 /PRNewswire-USNewswire/...examining whether a smokeless, spitless tobacco pr...e researchers have found that RJ Reynolds, Camel S...fy addiction - contains surprisingly high levels o...icotine than most other snuff products," said Bruc...
(Date:11/21/2008)...NEW YORK, Nov. 21 The general memb...ted to induct three new individuals at their Annua...he Pierre hotel in New York. A,Lifetime Achieveme...uctees into the Medical Advertising Hall of Fame a...g career with an account position,at Sudler &...
(Date:11/21/2008)...Experiments in mice find running increases product.... 21 (HealthDay News) -- In experiments in mice, e...uction of brain stem cells usually seen with aging...le restoration of the brain,s ability to stave off...restore a neurochemical that is essential for the ...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Exercise Keeps the Brain Young 2
...n models were kicked out of a Rome fashion show la... on anorexia in the fashion industry . "I asked t...k ... (and) had to fire 15 who were under (French)...)," Raffaella Curiel told reporters. "One girl fa...
... antibiotics daily to prevent future urinary tract...ot be such a good idea , for not only does it not ...hat bacteria causing the infection might develop r...g is based on the first large study of children di...
...chers reported the substance, known as adiponecti...ergy expenditure in an effort to maintain adequate...tein known for its effects on the liver and skelet...e as an energy-conserving signal to the brain duri...
...seems to be an acute shortage of jobs for the phys...d physiotherapists cannot find a permanent job in...There is huge waiting list of patients waiting for...inancial cutback last year to balance health servi...
Other Medicine News:Health News:Daily Antibiotics may Not Prevent Future Urinary Tract Infections Risk in Kids 2Health News:Insulin Sensitizer- Energy Conserving Signal to Brain 2Health News:Physios Find It Difficult to Find Job in NHS 2
(Date:11/20/2008)...ASHINGTON, Nov. 20 The ...amp; Gender Equity: , , WHAT: World AIDS ... Tuesday, November 25, 2008 , 11:00 a.m. EST ...ngly encouraged: https://cc.readytalk.com/r/1xe41...s outpacing the number of people newly put on trea...
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 1Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 2MIT develops thin film micro pharmacy 11580 1MIT develops thin film micro pharmacy 11580 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 1Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 1Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 2Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 4Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 5Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 6Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 7Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 8Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 9
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: